References
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
- Hu ZB, Chen JP, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008;118(7):2600–2608. doi:10.1172/JCI34934
- Lin YD, Ge YQ, Wang YY, et al. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population. Gene. 2017;627(5):226–232. doi:10.1016/j.gene.2017.06.021
- Bi YH, Cui ZG, Zhou BS, Yin ZH. Polymorphisms in long noncoding RNA-prostate cancer-associated transcript 1 are associated with lung cancer susceptibility in a Northeastern Chinese population. DNA Cell Biol. 2019;38(11):1357–1365. doi:10.1089/dna.2019.4834
- Li LJ, Sun RF, Liang YD, et al. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J Exp Clin Cancer Res. 2013;32(1):104–111. doi:10.1186/1756-9966-32-104
- Xu T, Hu XX, Liu XX, et al. Association between SNPs in long non-coding RNAs and the risk of female breast cancer in a Chinese population. J Cancer. 2017;8(7):1162–1169. doi:10.7150/jca.18055
- Kasagi Y, Oki E, Ando K, et al. The expression of CCAT2, a novel long noncoding RNA transcript, and rs6983267 single-nucleotide polymorphism genotypes in colorectal cancers. Oncology. 2017;92(1):48–54. doi:10.1159/000452143
- Yeager M, Orr N, Hayes R, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39:645–649. doi:10.1038/ng2022
- Yadav S, Chandra A, Kumar A, Mittal B. Association of TERT-CLPTM1L and 8q24 common genetic variants with gallbladder cancer susceptibility and prognosis in North Indian population. Biochem Genet. 2018;56(4):267–282. doi:10.1007/s10528-018-9843-z
- Wu ER, Hsieh MJ, Chiang WL, et al. Association of lncRNA CCAT2 and CASC8 gene polymorphisms with hepatocellular carcinoma. Int J Environ Res Public Health. 2019;16(16):2833–2844. doi:10.3390/ijerph16162833
- Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;15(1):193–203. doi:10.1016/j.chest.2016.10.010
- Wacholder S, Chanock S, Garcia-Closas M, Ghormli LE, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–442. doi:10.1093/jnci/djh075
- Chung S, Nakagawa H, Uemura M, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 2011;102(1):245–252. doi:10.1111/j.1349-7006.2010.01737.x
- Sattarifard H, Hashemi M, Hassanzarei S, Narouie B, Bahari G. Association between genetic polymorphisms of long non-coding RNA PRNCR1 and prostate cancer risk in a sample of the Iranian population. Mol Clin Oncol. 2017;7(6):1152–1158. doi:10.3892/mco.2017.1462
- AlMutairi M, Parine NR, Shaik JP, et al. Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population. PLoS One. 2019;14(9):e0220931. doi:10.1371/journal.pone.0220931
- Choi YJ, Myung SK, Lee JH. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res Treat. 2018;50(2):474–487. doi:10.4143/crt.2017.094
- Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011;145(2):178–181. doi:10.1016/j.cell.2011.03.014
- Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446–1461. doi:10.1101/gr.152942.112
- Łaźniak S, Lutkowska A, Wareńczak-Florczak. Ż, et al. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population. Arch Gynecol Obstet. 2018;297(5):1285–1292. doi:10.1007/s00404-018-4740-6
- Zhang X, Chen Q, He C, et al. Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese. PLoS One. 2012;7(7):e41930. doi:10.1371/journal.pone.0041930
- Redis RS, Vela LE, Lu WQ, et al. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell. 2016;61(4):520–534. doi:10.1016/j.molcel.2016.01.015
- Gong WJ, Yin JY, Li XP, et al. Association of well-characterized lung cancer LncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumor Biol. 2016;37(6):8349–8358. doi:10.1007/s13277-015-4497-5
- Qiu M, Xu Y, Yang X, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biol. 2014;35(6):5375–5380. doi:10.1007/s13277-014-1700-z
- He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging. 2019;11(15):5744–5756. doi:10.18632/aging.102157
- Xu S, Huang H, Chen Y-N, et al. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21 WAF1/CIP1. Cell Cycle. 2016;15(21):2920–2930. doi:10.1080/15384101.2016.1224043
- Spiller CM, Lobo J, Boellaard WPA, Gillis AJM, Bowles J, Looijenga LHJ. CRIPTO and miR-371a-3p are serum biomarkers of testicular germ cell tumors and are detected in seminal plasma from azoospermic males. Cancers (Basel). 2020;12(3):760. doi:10.3390/cancers12030760
- Mego M, van Agthoven T, Gronesova P, Chovanec M. Clinical utility of plasma miR-371a-3p in germ cell tumors. J Cell Mol Med. 2019;23(2):1128–1136. doi:10.1111/jcmm.14013
- Han X, Xing L, Zhao H, et al. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma. J Cell Biochem. 2019;120(9):15834–15843. doi:10.1002/jcb.28854
- Bai M, Che Y, Lu K, Fu L. Analysis of deubiquitinase OTUD5 as a biomarker and therapeutic target for cervical cancer by bioinformatic analysis. PeerJ. 2020;8:e9146. doi:10.7717/peerj.9146